In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Postmarket Transformation Plan Update With FDA’s Don St. Pierre

This article was originally published in The Gray Sheet

Executive Summary

FDA's device center set out on an ambitious path last year to revamp the way it oversees product safety in what it is calling its 1"postmarket transformation" initiative

You may also be interested in...



New CDRH Decision Methods Will Be Put To The Test, Starting With Stents

Defining a "new science" for post-market surveillance is a top priority for the FDA device center's post-market group, according to the program's new leader

New CDRH Decision Methods Will Be Put To The Test, Starting With Stents

Defining a "new science" for post-market surveillance is a top priority for the FDA device center's post-market group, according to the program's new leader

FDA May Wield Prosecutorial Authority More Frequently

Device companies can expect more active legal prosecution by FDA for off-label and product safety issues as the agency improves its ability to track products on the market and as the activity of industry whistleblowers grows, according to government and agency staffers

Related Content

UsernamePublicRestriction

Register

MT025000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel